The present disclosure provides, inter alia, RAF-Degrading Conjugate Compounds that are useful in the treatment of cancer and other RAF related diseases. Also provided are, pharmaceutical compositions, methods of treatment, and kits comprising a RAF- Degrading Conjugate Compound.
-
(2018/11/22)
HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS
The present invention provides compounds of formula (I) useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf -mediated diseases.
-
Page/Page column 79; 80
(2010/08/04)
COMPOUNDS USEFUL AS RAF KINASE INHIBITORS
The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
-
Page/Page column 80
(2009/03/07)
Heterocyclic Compounds Useful as RAF Kinase Inhibitors
The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
-
Page/Page column 36
(2009/01/24)
More Articles about upstream products of 1095823-56-5